Smith DE - Search Results

1

Revisiting atenolol as a low passive permeability marker.

Chen X, Slättengren T, de Lange ECM, Smith DE, Hammarlund-Udenaes M. Chen X, et al. Among authors: smith de, de lange ecm. Fluids Barriers CNS. 2017 Oct 31;14(1):30. doi: 10.1186/s12987-017-0078-x. Fluids Barriers CNS. 2017. PMID: 29089037 Free PMC article.

2

Effect of transporter inhibition on the distribution of cefadroxil in rat brain.

Chen X, Loryan I, Payan M, Keep RF, Smith DE, Hammarlund-Udenaes M. Chen X, et al. Among authors: smith de. Fluids Barriers CNS. 2014 Nov 14;11(1):25. doi: 10.1186/2045-8118-11-25. eCollection 2014. Fluids Barriers CNS. 2014. PMID: 25414790 Free PMC article.

3

Influence of peptide transporter 2 (PEPT2) on the distribution of cefadroxil in mouse brain: A microdialysis study.

Chen X, Keep RF, Liang Y, Zhu HJ, Hammarlund-Udenaes M, Hu Y, Smith DE. Chen X, et al. Among authors: smith de. Biochem Pharmacol. 2017 May 1;131:89-97. doi: 10.1016/j.bcp.2017.02.005. Epub 2017 Feb 10. Biochem Pharmacol. 2017. PMID: 28192085 Free PMC article.

4

Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1.

Hu Y, Chen X, Smith DE. Hu Y, et al. Among authors: smith de. Drug Metab Dispos. 2012 Jul;40(7):1328-35. doi: 10.1124/dmd.111.044263. Epub 2012 Apr 9. Drug Metab Dispos. 2012. PMID: 22490229 Free PMC article.

5

Development and characterization of a novel mouse line humanized for the intestinal peptide transporter PEPT1.

Hu Y, Xie Y, Wang Y, Chen X, Smith DE. Hu Y, et al. Among authors: smith de. Mol Pharm. 2014 Oct 6;11(10):3737-46. doi: 10.1021/mp500497p. Epub 2014 Sep 2. Mol Pharm. 2014. PMID: 25148225 Free PMC article.

6

Professor Margareta Hammarlund-Udenaes - Humbled Scientist Shaping Modern Neuropharmacokinetics.

Loryan I, Smith DE, Artursson P, Breimer D, Deguchi Y, Paalzow L, Sugiyama Y, Terasaki T, de Lange ECM. Loryan I, et al. Among authors: smith de, de lange ecm. Pharm Res. 2022 Jul;39(7):1283-1289. doi: 10.1007/s11095-022-03279-x. Pharm Res. 2022. PMID: 35773367 No abstract available.

7

Differential recognition of ACE inhibitors in Xenopus laevis oocytes expressing rat PEPT1 and PEPT2.

Zhu T, Chen XZ, Steel A, Hediger MA, Smith DE. Zhu T, et al. Among authors: smith de. Pharm Res. 2000 May;17(5):526-32. doi: 10.1023/a:1007556630189. Pharm Res. 2000. PMID: 10888303 Free article.

8

Mechanisms of gemcitabine oral absorption as determined by in situ intestinal perfusions in mice.

Thompson BR, Hu Y, Smith DE. Thompson BR, et al. Among authors: smith de. Biochem Pharmacol. 2019 Oct;168:57-64. doi: 10.1016/j.bcp.2019.06.013. Epub 2019 Jun 14. Biochem Pharmacol. 2019. PMID: 31207211 Free PMC article.

9

Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice.

Shen H, Ocheltree SM, Hu Y, Keep RF, Smith DE. Shen H, et al. Among authors: smith de. Drug Metab Dispos. 2007 Jul;35(7):1209-16. doi: 10.1124/dmd.107.015263. Epub 2007 Apr 23. Drug Metab Dispos. 2007. PMID: 17452417

10

Choroid plexus transport: gene deletion studies.

Keep RF, Smith DE. Keep RF, et al. Among authors: smith de. Fluids Barriers CNS. 2011 Nov 4;8(1):26. doi: 10.1186/2045-8118-8-26. Fluids Barriers CNS. 2011. PMID: 22053861 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,352 results

Search Page

Filters